|
|
Arrhytmias in athletes
Alaskan sled dogs, R, RT-220
atrial fibrillation, OA, RT-223
blunt chest blow, OA, RT-221
cardiopulmonary resuscitation measures, OA, RT-221
cardiovascular preparticipation screening, OA, RT-218
commotio cordis syndome, OA, RT-221
congenital/acquired conduction system abnormalities, R, RT-220
dynamic exercise, OA, RT-219
echocardiography, OA, RT-218
electrical vulnerable period of repolarization, OA, RT-221
electrophysiologic testing, OA, RT-223
endurance training, OA, RT-219, RT-222
frequent/complex arrhythmias, OA, RT-218
head-up tilt testing, OA, RT-217
heart rate spectral analysis, OA, RT-219
heart rate variability, OA, RT-222
highly-trained athletes, OA, RT-217
hypertension, OA, RT-219
Iditarod race, R, RT-220
late potentials, OA, RT-218
magnetic resonance imaging, OA, RT-218
medium-trained subjects, OA, RT-217
middle-aged subjects, OA, RT-217
myocardial biopsy, OA, RT-218
neurally mediated syncope, OA, RT-217
pathologic conditions, OA, RT-222
physical training degree, OA, RT-217
physiologic vagotonia induced by training, OA, RT-222
power spectrum analysis, OA, RT-222
preventive measures, OA, RT-221
prolonged palpitations, OA, RT-223
sedentary subjects, OA, RT-217
strenuous physical activity, R, RT-220
subclinical heart disease, OA, RT-218
sudden death, OA, RT-221
sudden death, R, RT-220
sympatho-vagal balance modulation, OA, RT-222
sympatho-vagal balance, OA, RT-219
systemic sports training/competition, OA, RT-221
top-level athletes, OA, RT-223
transoesophageal atrial pacing/recoding, OA, RT-223
vagally-mediated heart rate recovery, OA, RT-219
ventricular arrhythmias, OA, RT-218
ventricular disrhythmia, OA, RT-221
|
|
Arrhytmogenic right ventricular dysplasia
angiotensin converting enzym inhibitor, OA, RT-206
asymptomatic/symptomatic patients, OA, RT-209
autosomic dominant disease, OA, RT-209
class I, II, IV drugs, OA, RT-206
congestive heart failure, OA, RT-207,
RT-209
dilated cardiomyopathy, OA, RT-207
exercise rest, OA, RT-209
family studies, OA, RT-209
functional/morphological characteristics, OA, RT-205
heart muscle disorder, OA, RT-205
heart transplantation, OA, RT-207
left bundle branch block QRS configuration, OA, RT-204,
RT-208
major/minor diagnosis criteria, OA, RT-205
pharmacologic treatment, OA, RT-209
progressive disease, OA, RT-209
propafenone, OA, RT-206
repolarization abnormalities in right precordial leads, OA, RT-208
rest, exercise, OA, RT-207
right ventricular angiography, OA, RT-205
signal averaged ECG, OA, RT-208
suden death, OA, RT-204
surface 12 -lead ECG, OA, RT-208
wall motion abnormalities, OA, RT-207
young patients, OA, RT-209
|
TOP OF THE PAGE
|
Arrhytmhogenesis
acute ischemia, OA, RT-133
autonomic nervous system, R, RT-134
circadian variations, R, RT-134
conductin delay, OA, RT-133
controle of ventricular repolarization, OA, RT-135
defibrillation threshold, R, RT-132
gene disease, OA, RT-135
genotype, OA, RT-135
inhomogeneity of repolarisation, R, RT-132
ischemia threshold, R, RT-134
long QT syndrome, OA, RT-135
phenotype, OA, RT-135
QT dispersion, R, RT-132
silent myocardial ischemia, R, RT-134
ST-changes, OA, RT-133
thrombus fomation, OA, RT-133
trigger/substrate interaction, R, RT-132
ventricular fibrillation threshold, R, RT-132
|
TOP OF THE PAGE
|
Atrial fibrillation
AF substrate ablation, R, S-3
anatomic patterns, OA, RT-77
anxiety, OA, RT-14
atrial activation pattern, OA, RT-81
atrial effective refractory period, OA, RT-77
atrial endocardial mapping, OA, RT-78
atrial mapping, OA, RT-81
atrial refractoriness, OA, RT-76
AV node ablation, R, S-3
AV node modulation, R, S-3
bipolar electrogram patterns, OA, RT-77
bradi-tachycardia patients, OA, RT-59
catheter ablation in right atrium, OA, RT-81
catheter ablation, R, RT-79
chronic AF, OA, RT-191
chronotropic incompetence, OA, RT-59
class 1c drugs, OA, RT-56
clinical implications, R, RT-80
consisten atrial pacing algorithm, OA, R-57
conversion of atrial fibrillation to sinus rhythm, OA, RT-54, RT-56
di-sotalol, OA, RT-76
discomfort, OA, RT-191
dominating atrial cycle length, OA, RT-76
drug protocols, OA, RT-54
dual chamber pacemaker, OA, RT-58, RT-59
effective refractory period, OA, RT-49
efficacy, OA, RT-191
electrical remodelling, OA, RT-49
family interaction, OA, RT-14
Framingham study, OA, RT-54, RT-191
Framingham study, R, S-3
Freiburger personality inventory, OA, RT-14
hemodialysis patients, OA, RT-53
hobby activities, OA, RT-14
Holter ECG, OA, R-57
ICD therapy, OA, RT-14
idiopathic atrial fibrillation, OA, RT-78
implantable atrial defibrillator, OA, RT-191
interatrial septum pacing, OA, S-2
interatrial conduction time, OA, S-2
Metrix multicenter clinical trial, OA, RT-191
Multiploar Mapping Basket Catheter, R, RT-79
multisite mapping of activation, R, RT-79
muscle tension, OA, RT-14
non-invasive assessment, OA, RT-76
P wave duration, OA, S-2
paroxysmal atrial fibrillation, OA, S-2, RT-77
patterns of activation, OA, RT-78
personality structure, OA, RT-14
prediction of arrhythmias, OA, RT-49
proarrhythmia, OA, RT-191
propafenone, OA, RT-53
prophylaxis of atrial fibrillation, OA, RT-53
quality of life, OA, RT-14
radiofrequency catheter ablation, R, RT-80, S-3
recurrent paroxysmal atrial fibrillation, OA, R-57,
RT-58, RT-59
refractory AF, OA, RT-191
role of intra-atrial conduction, OA, RT-58
role of supraventricular tachycardias, R, RT-80
sinus sick syndrome, OA, RT-59
social demographic data, OA, RT-14
sympathetic stimulation, OA, RT-76
tachycardia induced atrial fibrillation, R, RT-80
tolerability, OA, RT-191
vagal stimulation, OA, RT-76
|
TOP OF THE PAGE
|
Atrial fibrillation - electrophysiology
ablation of arrythmogenic substrates, OA, S-23
atrial effective refractory period, OA, RT-246
catheter ablation, R, RT-75
computerized analysis of intra-atrial potentials, OA, RT-247
conduction velocity, OA, RT-247
coronary artery disease, OA, RT-246
cycle length of AF waves, OA, RT-245
dilated cardiomyopathy, OA, RT-246
Doppler echocardiography, OA, RT-245
elctrophysiology substrate, R, RT-75
electrical remodeling, R, RT-75
left atrial appendage wall velocity, OA, RT-245
mapping, R, RT-75
mechanisms of AF perpetuation, OA, RT-246, RT-247
non-fluoroscopic electro-anatomical mapping, OA, S-23
pacing-induced AF, OA, RT-246
pulsed wave tissue Doppler imaging, OA, RT-245
refractoriness, OA, RT-247
tissue Doppler imaging, OA, RT-245
wave-length of circulating impulse, OA, RT-247
|
TOP OF THE PAGE
|
Atrial fibrillation RF catheter ablation
of AV junction
automatic mode-switch activations/day ratio, OA, RT-145
brady-tachy syndrome, OA, RT-149
chronic AF, OA, RT-147
clinical outcome, OA, RT-147
dicumarol, OA, RT-148
dual chamber pacemaker, OA, RT-145
epidemiology, OA, RT-146
idiopathic ventricular tachyarrhythmias, OA, RT-150
left bundle brunch block configuration, OA, RT-150
magnetic resonance imaging, OA, RT-152
mortality rate, OA, RT-147
NYHA class, OA, RT-148
pacemaker (DDD, VVI mode), OA, RT-149
pacemaker (DDD, VVIR mode), OA, RT-148
pacemaker (DDDR mode), OA, RT-146
pacing mode (DDD, DDDR, VDD), OA, RT-145
PAF trial, OA, RT-146
pharmacological treatment, OA, RT-146
refractory ventricular ectopic beats, OA, RT-151,
RT-152
right ventricle abnormalities, OA, RT-152
right ventricular cardiomyopathy, OA, RT-150
right ventricular outflow tract, OA, RT-151,
RT-152
right ventricular tachyarrhythmias, OA, RT-150
supraventrucular arrhythmias, OA, RT-148
thromboembolisms, OA, RT-147
ventricular function, OA, RT-148
|
TOP OF THE PAGE
|
Atrial fibrillation thromboembolic events
ACUTE trial, OA, RT-142
apendage thrombus, OA, RT-140
calcic and sodium heparin, OA, RT-142
dicoumarol, OA, RT-142
intra-atrial thrombus, OA, RT-140
onset of arrhythmias, OA, RT-140
thrombus organization, OA, RT-141, RT-143
thrombus resolution, OA, RT-141, RT-143
|
TOP OF THE PAGE
|
Atrial fibrillation - transthoracic electrical
cardioversion
adverse events, OA, RT-137
antero-posterior versus antero-lateral position, OA, RT-136
anticoagulation therapy, OA, RT-137
arrhythmia duration, OA, RT-138
atrial contractile function, OA, RT-139
atrial stunning, OA, RT-139
DC-schock energy requirements, OA, RT-136
defibrillator paddle position, OA, RT-136
efficacy, OA, RT-137
heart rate, OA, RT-139
history of previous episodes of AF, OA, RT-138
optimal cardioversion energy, OA, RT-137
predictors of cardioversion, OA, RT-138
risk of thromboembolism, OA, RT-139
risk stratification of stroke, OA, RT-137
role of permanent atrial pacing, OA, RT-139
transthoracic impedance, OA, RT-136
|
TOP OF THE PAGE
|
Atrial fibrillation transvenous internal
cardioversion
AF defibrillation threshold, R, RT-189
amiodarone, R, RT-189
antiarrhythmic therapy influence, R, RT-189
atrial defibrillation threshold, OA, RT-186, RT-187
biphasic shock, OA, RT-187
chronic AF, OA, RT-185
clas I, Ic, III drugs, R, RT-189
d-sotalol, flecainide, R, RT-189
efficacy, OA, RT-187
endocavitary atrial cardioversion, OA, RT-186
external cardioversion, OA, RT-186
external cardioversion, R, RT-189
flecainide, R, RT-189
frequency domain ananlysis, OA, RT-188
ICD inappropriate incidences, OA, RT-184
inter-subject variability in schock tolerability, OA, RT-185
low energy atrial cardioversion, OA, RT-187,
RT-188
low energy atrial defibrillation, OA, RT-184,
RT-185, RT-186
P wave signal averaging, OA, RT-188
patch electrode, OA, RT-184
pharmacologic pre-treatment, OA, RT-187
prediction of early AF relaps, OA, RT-188
propafenone, R, RT-189
right atrium-coronary sinus configuration, OA, RT-187
right atrium-left pulmonary artery configuration, OA, RT-187
right atrium-right ventricle coil-lead configuration, OA, RT-186
single/dual pathway simultaneous biphasic shocks, OA, RT-184
step-up protocol for schock delivery, OA, RT-185
time domain analysis, OA, RT-188
ventricular proarrhythmia, OA, RT-185
|
TOP OF THE PAGE
|
Autonomic nervous system evaluation
arrhythmogenic substrate, OA, RT-211
ATRAMI trial, R, RT-212
autonomic control of circulation, OA, RT-210
autonomic markers, R, RT-212
baroreceptor function, OA, RT-210
baroreflex sensitivity, R, RT-212
EMIAT trial, R, RT-212
GISSI-3 Arrhythmias subtrial, OA, RT-211
head-up tilt testing, OA, RT-210
heart rate variability, R, RT-212, RT-213
high-frequency spectral component, R, RT-213
Holter ECG, OA, RT-211
left ventricular function, R, RT-212
lethal arrhythmias, R, RT-212
lisinopril, OA, RT-211
low-frequency spectral component, R, RT-213
MADIT trial, R, RT-212
markers of vagal/sympathetic modulation, R, RT-213
mortality risk, OA, RT-211
neural code, R, RT-213
neurocardiogenic syncope, OA, RT-210
postmyocardial patients, OA, RT-211
postmyocardial patients, R, RT-212
reflex chronotropic response to a blodd pressure change, R, RT-212
risk stratification, R, RT-212
sympatho-vagal balance, R, RT-213
transdermal glyceryl trinitrate, OA, RT-211
ventricular function, OA, RT-211
|
TOP OF THE PAGE
|
Brugada, Martini-Nava syndromes
amiodarone, OA, RT-243
arrhythmogenic right ventricular cardiomyopathy, OA, RT-242
beta-blockers, OA, RT-243
conduction system disease, OA, RT-242
family ECG screening, OA, RT-243
family incomplete bundle branch block, OA, RT-244
genetic screening, OA, RT-244
intraventricular delay, OA, RT-244
magnetic resonance imaging, OA, RT-244
middle-aged patients, OA, RT-243
right bundle branch block, OA, RT-242,
RT-243
right precordial ST segment elevation, OA, RT-242,
RT-243, RT-244
right ventricle dysplasia cardiomyopathy syndrome, OA, RT-244
syncope, OA, RT-242
V1-V3 ECG leads, OA, RT-243
young patients, OA, RT-242
|
TOP OF THE PAGE
|
Cardiac arrhythmias - classification
anatomic inaccuracy, R, RT-177
anatomical nomenclature, R, RT-177
atrial fibrillation, R, RT-178
atrial tachycardia classification, R, RT-178
atrial-ventricualr arrhythmias, R, RT-177
focal atrial tachycardia, R, RT-178
macro-reentrant atrial tachycardia, R, RT-178
substrate-based classification, R, RT-178
syndrome of inappropriate sinus tachycardia, R, RT-178
tachycardia substrate geometry, R, RT-178
uniform heart structures terminology, R, RT-177
|
TOP OF THE PAGE
|
Cardiac arrhythmias - epidemiology
analysis of arrhythmologic literature, OA, RT-86
analysis of resource use, OA, RT-89
bootstrap method, RT-87
borreliosis, RT-87
cardiac arrhythmias, RT-87
cardiac operations, RT-88
Catalog of Medical Acts, OA, RT-89
drug costs, RT-88
epidemiologic methods, OA, RT-86
Europe, OA, RT-90
financing hospitals, OA, RT-89
France, OA, RT-89
health economics, RT-88
hospital productivity, OA, RT-89
Italy, OA, RT-89
Lyme disease, RT-87
pacemakers, RT-88
public health system, OA, RT-89
registry of ICD, Europe, OA, RT-90
registry of pacemakers, Europe, OA, RT-90
risk assessment, RT-87
statistical analysis, OA, RT-86
|
TOP OF THE PAGE
|
Cardiac arrhythmias gender differences
acute ischemic syndrome, OA, RT-240
aspirin, OA, RT-239
Austrian Pacemaker Database, OA, RT-240
AV block, OA, RT-240
beta-blockers, OA, RT-239
bradyarrhythmias, OA, RT-240
congestive heart failure, OA, RT-239
coronary artery bypass graftings, OA, RT-239
coronary artery disease, OA, RT-241
crude mortality, OA, RT-239
diabetes, OA, RT-239
diagnostic/therapeutic procedures, OA, RT-240,
RT-241
epidemiology, OA, RT-240
European Pacemaker Patient Identification Card, OA, RT-241
gender discrimination of management, OA, RT-240,
RT-241
hypertension, OA, RT-239
nitrates, OA, RT-239
pacemaker implantation, OA, RT-241
postmenopausal women, OA, RT-241
postmyocardial infarction, OA, RT-239
quality of treatment, OA, RT-240
selection of pacing mode, OA, RT-240,
RT-241
sequential pacing mode (DDD, DD-R, DD-M), OA, RT-241
single-lead pacing (VVI, VVI-R mode), OA, RT-241
sinus sick syndrome, OA, RT-240
TAMI trial, OA, RT-240
thrombolytic therapy, OA, RT-240
ventricular arrhythmias, OA, RT-239
Yentl syndrome, OA, RT-240
|
TOP OF THE PAGE
|
Cardiac arrhythmias mapping
atrial tachycardia, OA, RT-195
mapping techniques, OA, RT-195
AP interval, OA, RT-195
atrial activation, OA, RT-195
pacemapping concordant sequence, OA, RT-195
radiofrequency catheter ablation, OA, RT-195
automaticity of ectopic focus, OA, RT-195
intra-atrial/sino-atrial node reentry, OA, RT-195
epicardial mapping, OA, RT-192
endocardial mapping, OA, RT-192
postmyocardial patients, OA, RT-192
pleomorphic ventricular tachycardia, OA, RT-192
radiofrequency catheter ablation, OA, RT-192
|
TOP OF THE PAGE
|
Cardiac surgery - arrhythmias
atrial fibrillation, OA, RT-93
corridor procedure, R, RT-91
ectopic atrial tachycardia, R, RT-91
left atrial isolation,OA, RT-93
Maze operation, OA, RT-93
Maze operation, R, RT-91
mitral valve disease, OA, RT-93
radiofrequency ablation, R, RT-91
|
TOP OF THE PAGE
|
Catheter ablation of supraventricular
tachyarrhythmias
amiodarone, OA, RT-162
anatomic/electrophysiologic approach, OA, RT-161
atrial flutter (typical - type I), OA, RT-161
atrioventricular junctional reciprocating tachycardia, OA, RT-157
AV node modification, OA, RT-157
beta-blockers, R, RT-158
bidirectional conduction block, OA, RT-161
catheter ablation, R, RT-158
chronic non-paroxysmal sinus tachycardia, R, RT-158
class Ia, Ic, III drugs, OA, RT-162
counterclockwise circular activation, OA, RT-160
flecainide, OA, RT-162
inappropiate sinus tachycardia, R, RT-158
index of successful ablation, OA, RT-161
junctional accelerated rhythm, OA, RT-157
mechanisms of induction of AFl, OA, RT-160
programmed stimulation, OA, RT-160
propafenone, OA, RT-162
quinidine, OA, RT-162
recurrence of AF, OA, RT-162
right atrial activation sequence, OA, RT-161
slow pathway ablation, OA, RT-157
sotalol, OA, RT-162
verapamil, R, RT-158
|
TOP OF THE PAGE
|
Heart rate variability
acute myocardial infarction, OA, RT-105
aerobic exercise training, OA, RT-233
arrhythmogenic right ventricular cardiomyopathy, OA, RT-232
autonomic nervous system, OA, RT-231,
RT-232
cardiac rehabilitation, OA, RT-231
dynamic exercise, OA, RT-233
essential hypertension, OA, RT-233
fractal dimension analysis, OA, RT-51
frequency domain, OA, RT-231
heart rate spectral analysis, OA, RT-233
Holter ECG, OA, RT-232
hypotensive effect of exercise training, OA, RT-233
isometric exercise, OA, RT-233
late potentials, OA, RT-105
left ventricular ejection fraction, OA, RT-105
myocardial infarction, OA, RT-232
non-linear dynamics analysis, OA, RT-51
post myocardial infarction, OA, RT-231
postischemic recovery, OA, RT-51
prediction of arrhythmias, OA, RT-51
risk stratification, OA, RT-105
sympathetic activity, OA, RT-232
sympatho-vagal activity, OA, RT-233
time domain analysis, OA, RT-231, RT-232
ventricular arrhythmias, OA, RT-232
|
TOP OF THE PAGE
|
Hypertrophic cardiomyopathy
antiarrhythmic drug therapy, R, RT-30
implantable cardioverter defibrillator, R, RT-30
markers of sudden death (clinical, ECG), R, RT-29
programmed electrical stimulation, R, RT-29
QT interval dispersion, R, RT-31
risk factor stratification, R, RT-29,
RT-31
sudden death, R, RT-31
T wave alternans, R, RT-31
treatment of risk factors, R, RT-29
|
TOP OF THE PAGE
|
Implantable cardioverter defibrillator
function, indications
atrial signal analysis, OA, S-114
atrium/ventricle sensing-pacing, R, RT-201
atriventricular discrimination algorithm, OA, S-10
antitachycardia pacing algorithms, CR, S-11
arrhythmia detection algorithm, OA, S-114
automatic sensitivity control, R, S-9
automatic sensitivity programming, R, S-9
AVID trial, R, S-6
beta-blockers, R, RT-201
biphasic shock, OA, RT-203
CASH trial, R, S-6
CIDS trial, R, S-6
cellular phones, OA, RT-99
DDD pacing, R, RT-201
DDDR pacing, R, RT-201
DDI pacing, R, RT-201
DDIR pacing, R, RT-201
defibrillation efficacy, OA, RT-203
defibrillation threshold, OA, RT-203
dilated cariomyopathy, R, RT-201
discrimination ventricular/supraventricular tachycardias, OA, S-4, S-114
dual chamber detection algorithm, OA, S-4
dual chamber ICD, OA, S-114
dual chamber ICD, R, RT-201
dual chamber pacing, OA, S-4
electrical shock, OA, RT-202
electromagnetic interference, OA, RT-99
GSM technology, OA, RT-99
hypertrophic obstructive cardiomyopathy, R, RT-201
ICD inappropriate incidences, OA, S-114
inappropriate ICD incidences, OA, RT-202
inappropriate ICD incidences, R, RT-201
indications, R, RT-201
loss of consciousness, OA, RT-202
painless defibrillator, OA, RT-202
postinfarction patients, R, RT-201
prediction of arrhythmias, OA, S-8
prevention, OA, S-4
programming and telemetric check up, OA, RT-99
prophylactic ICD trials, R, S-6
quality of life, OA, RT-202
RR variability, OA, S-8
sensing circuitry, R, S-9
severe left ventricular function, R, RT-201
single chamber ICD, OA, S-114
SMART algorithm, OA, S-10
supraventricular arrhythmias, OA, S-10
TACS technology, OA, RT-99
therapy ventricular arrhythmias versus supraventricular arrhythmias, OA, S-4
VDD pacing, R, RT-201
ventricular arrhythmias, R, S-6
ventricular tachycardia, CR, S-11
VVI (ventricular) pacing, R, RT-201
|
TOP OF THE PAGE
|
Implantable cardioverter defibrillator new
perspectives
antibradycardia pacing, R, S-165
antitachycardia pacing, R, S-165
arrhythmias detection algorithms, R, S-164
arrhythmias detection, R, S-163
arrhythmias therapy, R, S-163
atrial pacing, R, S-165
atrioventricualr pacing, R, S-165
atriventricular association algorithm, R, S-166,
S-167
clinical results, R, S-166
defibrillation, R, S-165
detection of RR intervals, R, S-167
French multicenter trial, R, S-166
Holter ECG, R, S-163
ICD inappropriate incidences, R, S-164,
S-166
low energy cardioversion, R, S-165
pacemaker function, R, S-163
PARAD decision tree, R, S-167
paroxysmal AF, R, S-165
single chamber ICD, R, S-163
sudden cardiac death, R, S-165
VAN detection algorithms, R, S-166
ventricualr tachycardia/fibrillation, R, S-165
ventricular signal-based detection criteria, R, S-167
ventricular tachycardia persistence, R, S-167
|
TOP OF THE PAGE
|
Implantable cardioverter defibrillator
prevention of sudden death
amiodarone, R, RT-216
AVID trial, R, RT-215
BEST ICD trial, R, RT-216
beta-blockers, R, RT-216
CABG trial, R, RT-216
CASH trial, R, RT-215
CIDS trial, R, RT-215
class I drugs, R, RT-214
class I, III drugs, R, RT-216
cost-effectivenes analysis, R, RT-216
dl-sotalol, R, RT-216
electrical instability evaluation technique, R, RT-215
MUSTT trial, R, RT-216
non-sustained ventricular tachycardia, R, RT-214,
RT-215, RT-216
prophylatic ICD implantation, R, RT-214,
RT-215, RT-216
risk stratification, R, RT-214, RT-215
SCD-HeFT trial, R, RT-216
SWORD trial, R, RT-215
|
TOP OF THE PAGE
|
Implantable cardioverter defibrillator -
therapy
detection criteria, OA, S-115
detection criteria, R, S-113
ICD inappropriate incidences, OA, S-115
ICD inappropriate incidences, R, S-113
infectious complications, R, RT-101
morphology discrimination algorithm, OA, S-115
non-thoracotomy/thoracotomy approach, R, RT-101
onset criteria, R, S-113
prevention, R, RT-101
prevention of inappropriate incidences, R, S-113
stability criteria, R, S-113
staphylococcus aureus, R, RT-101
supraventricular tachycardia, OA, S-115
supraventricular tachycardia, R, S-113
treatment, R, RT-101
|
TOP OF THE PAGE
|
Long QT syndrome
body surface mapping, OA, RT-94
congenital/acquired syndrome, OA, RT-225
functional, OA, RT-94
lethal tachyarrhythmias, OA, RT-225
malignant ventricular arrhythmia, OA, RT-94
morphological and clinical features, OA, RT-94
neuronal degeneration, OA, RT-225
primary cardioneuropathy, OA, RT-94
sympathetic cardiac reflexogenic modulation, OA, RT-225
thoracic spinal cord sympathetic center, OA, RT-225
|
TOP OF THE PAGE
|
Major clinical trials
antiadrenergic action, R, RT-182
arrhythmia risk, R, RT-183
arrhytmia risk markers, R, RT-180
BASIS trial, R, RT-182
BEST-ICD trial, R, RT-183
CABG-Patch trial, R, RT-183
CASCADE trial, R, RT-182
CAST II trial, R, RT-182
CAST trial, R, RT-182
class I, Ic, III drugs, R, RT-182
DEBUT trial, R, RT-183
dl-sotalol, R, RT-182
d-sotalol, R, RT-182
ECG Holter substudies, R, RT-180
ESVEM trial, R, RT-182
European Guidelines, R, RT-183
GESICA trial, R, RT-182
MADIT II trial, R, RT-183
moricizine, R, RT-182
NORDIC trial, R, RT-183
Polish arrhythmia trial, R, RT-182
primary prevention of ventricular tachyarrhythmias, R, RT-182
proarrhythmia, R, RT-182
reduced left ventricular ejection fraction, R, RT-179,
RT-180, RT-183
SCD-HeFT trial, R, RT-183
secondary prevention of ventricular tachyarrhythmias, R, RT-182
sudden death, R, RT-183
SWORD trial, R, RT-182
ventricular tachycardias, R, RT-183
|
TOP OF THE PAGE
|
Mechanisms of arrhythmogenesis - experimental
arrhythmology
arrhythmogenic mechanisms, OA, RT-83
cellular ionic mechanisms, OA, RT-83
failing ventricular myocytes, OA, RT-83
heart failure, OA, RT-83
high K+, OA, RT-84
Purkinje fibers, OA, RT-84
sino-atrial node, OA, RT-84
sympathetic system, OA, RT-84
|
TOP OF THE PAGE
|
Molecular biology - mechanisms of
arrhythmogenesis
automacity, R, S-64
CAST trial, R, S-64
reentry, R, S-64
triggered activity, R, S-64
|
TOP OF THE PAGE
|
Molecular biology - structural anatomy and
pathology
apoptic bouts, R, RT-128
apoptosis, R, RT-128
arrhythmogenic right ventricular cardiomyopathy, R, RT-128
arrhythmogenic right ventricular dyspalsia, R, RT-126
atrioventricular conduction system, OA, RT-122
atrioventricular conduction system, R, RT-123
automatic arrhythmias, R, RT-124
Brugadaดs syndrome, R, RT-126
cardiac morphogenesis, R, RT-128
cellular ionic mechanisms, R, RT-125
congenital cardiac diseases, R, RT-125,
RT-126
congenital complete heart block, R, RT-125
electrophysiological mapping, OA, RT-122
famial aftrial fibrillation, R, RT-126
familal heart block, R, RT-126
familial WPW syndrome, R, RT-126
heart failure, R, RT-125
histologic investigation of transcatheter ablation lesions, OA, RT-122
hypertrophic cardiomyopathy, R, RT-126
hypertrophy, R, RT-125
idiopathic ventricualr fibrillation, R, RT-126
mechanisms of arrhythmogenesis, R, RT-125
myocardial structure abnotmalities, R, RT-124
postinfarction remodeling, R, RT-125
programmed cell death, R, RT-128
recurrent arhythmias, R, RT-124
reentrant arrhythmias, R, RT-124
torsade de pointes, R, RT-125
transcatheter ablation therapy, R, RT-123
variations in morphology, R, RT-123
|
TOP OF THE PAGE
|
Norepinephrine, acetylcholine
arrhythmogenic actions, OA, RT-52
norepinephrine-acetylcholine interaction, OA, RT-52
Purkinje fibers, OA, RT-52
|
TOP OF THE PAGE
|
Pacemakers
cellular phones, OA, RT-97
electromagnetic interference, OA, RT-97
GSM technology, OA, RT-97
proarrhythmic effects, OA, RT-97
TACS technology, OA, RT-97
|
TOP OF THE PAGE
|
Pacing
congestive heart failure, OA, RT-26
drug refractoreness, R, S-1
electrode configuration, OA, RT-24,
RT-25, RT-26
follow-up, OA, RT-38
Fourier analysis, OA, RT-39
ischemic heart disease, OA, RT-40
morphological and biological changes of myocardium, OA, RT-28
multiplesite pacing, OA, RT-26
multisite atrial pacing, R, S-1
paroxysmal atrial arrhythmias, R, S-1
peak endocardial accelaration, OA, RT-40
radionuclide ventriculography, OA, RT-39
single pass lead, OA, RT-38
structure of the heart, OA, RT-28
VDD pacemakers, OA, RT-38, RT-39
|
TOP OF THE PAGE
|
Pacing congestive heart failure
amiodarone, OA, RT-234
angiotensin converting enzyme inhibitors, OA, RT-234
arrhythmic events, OA, RT-235
atrial fibrillation, OA, RT-238
benazapril, OA, RT-234
Captopril-Digoxin trial, OA, RT-234
cardiac output, OA, RT-238
catheter ablation of AV junction, OA, RT-238
CONSENSUS trial, OA, RT-234
dilated cardiomyopathy, OA, RT-235,
RT-237
dual chamber pacing, OA, RT-237
echocardiography, OA, RT-235
enalapril, OA, RT-234
exercise performance, OA, RT-238
GESICA trial, OA, RT-234
GISSI-3, OA, RT-234
heart rate variability indexes, OA, RT-235
Italian Network for Congestive Heart Failure, OA, RT-234
Italian Study on Stimulation in Cardiomyopathy/ISSC trial, OA, RT-237
left ventricular filling, OA, RT-237
lisinopril, OA, RT-234
non-sustained ventricualr tachycardia, OA, RT-234
optimized-programmed AV interval, OA, RT-237
proarrhythmia, OA, RT-234
quality of life, OA, RT-238
right ventricular pacing, OA, RT-238
risk stratification, OA, RT-235
signal-averaged ECG, OA, RT-235
V-Heft II trial, OA, RT-234
|
TOP OF THE PAGE
|
Pacing assessment follow-up
atrial sensed-ventricular paced stimulation, OA, RT-120
cause of chest pain, OA, RT-119
DDD pacemakers, OA, RT-118
DDD pacing, OA, RT-121
Doppler mitral velocity wave, OA, RT-118
echocardiography stress testing, OA, RT-119
interatrial conduction time, OA, RT-118
interatrial electromechanical conduction time, OA, RT-118
interatrial septum dual chamber pacemaker, OA, RT-121
oesophageal electrical stimulation, OA, RT-119
oesophageal pain threshold, OA, RT-119
optimal atrioventricular delay, OA, RT-120,
RT-121
transoesophageal cardiac pacing, OA, RT-119
VDD pacing, OA, RT-121
|
TOP OF THE PAGE
|
Pacing leads
removal methods, OA, RT-100
transfemoral approach, OA, RT-100
transjugular approach, OA, RT-100
|
TOP OF THE PAGE
|
Peadiatric arrhythmias - management
amiodarone, OA, RT-198
atrial programmed stimulation, OA, RT-200
atrioventricular reentry tachycardia, OA, RT-198
beta-blockers, OA, RT-196
drug resistance, OA, RT-198
effectiveness, OA, RT-199
electrical myocardial instability, OA, RT-197
electrophysiologic patterns, OA, RT-200
indications, OA, RT-199
neurocardiogenic syncope, OA, RT-196
propranolol, OA, RT-198
radiofrequency catheter abaltion, OA, RT-199,
RT-200
sudden death, OA, RT-197
sustained atrial tachycardia, OA, RT-200
tetralogy Fallot post-operation, OA, RT-197
tilt-up testing, OA, RT-196
ventricular arrhythmias, OA, RT-197
ventricular recovery time indexes, OA, RT-197
ventricular repolarization time indexes, OA, RT-197
ventricular/supraventricular tachyarrhythmias, OA, RT-198
|
TOP OF THE PAGE
|
QT interval
acute myocardial infarction, OA, RT-44
aortic stenosis, OA, RT-47
exercise stress test, OA, RT-42
healthy subjects, OA, RT-41
Holter ECG, OA, RT-43
obese patients, OA, RT-42
sudden death, OA, RT-42
ventricular recovery, OA, RT-47
ventricular repolarization, OA, RT-47
|
TOP OF THE PAGE
|
Radio frequency catheter ablation of
tachyarrhythmias
antimyosine monoclonal antibodies, OA, RT-107
assessement of anatomic lesions, R, RT-109
atrial arrhythmias, R, RT-109
atrioventricular nodal fast pathway, OA, RT-110
atrioventricular nodal reentrant tachycardia, OA, RT-227
echocardiogram, OA, RT-107
heart-lung index, OA, RT-107
intracardiac echocardiography, R, RT-109
mapping - ablation, R, RT-109
myocardial lesion, OA, RT-107
orthoptic cardiac transplantation, R, RT-108
parahissian accessory pathways, OA, RT-110
postoperative arrhythmias, R, RT-108
recipient - donor heart, R, RT-108
sinus tachycardia, OA, RT-110
slow pathway approach, OA, RT-227
transient parasympathetic denervation of sinus node, OA, RT-110
transoesophageal atrial pacing/recording, OA, RT-227
|
TOP OF THE PAGE
|
RR interval, repolarization, heterogeneity,
variability
12-lead ECG, OA, RT-175
arrhythmogenesis, OA, RT-175
atrial ectopic activity, OA, RT-174
atrial refractory period, OA, RT-174
autonomic nervous system, OA, RT-174
autonomic nervous system, R, RT-172
circadian patterns, R, RT-172
CRAFT trial, OA, RT-174
dispersion of ventricular repolarisation, OA, RT-173
d-sotalol, R, RT-172
ECG leads configutation, OA, RT-175
ectopic ventricular beats, OA, RT-175
Holter ECG, OA, RT-174
Holter ECG, R, RT-172
inhomogeneity of ventricular recovery time, OA, RT-175
Laser Holter System, OA, RT-174
LQT genotype, R, RT-172
LQT syndrome, R, RT-172
macro-reentrant basis, OA, RT-174
non-electrical trigger factors, OA, RT-174
paroxysmal AF, OA, RT-174
QR-RR relation, R, RT-172
QT interval dispersion, OA, RT-175
QT interval, R, RT-172
quinidine, R, RT-172
risk stratification, R, RT-172
RR variability, OA, RT-173
RR/RT-apex variability interaction, OA, RT-173
RR-QT coupling, OA, RT-173
ST changes, R, RT-172
ventricular repolarization duration, OA, RT-173
ventricular repolarization dynamics, R, RT-172
|
TOP OF THE PAGE
|
Signal averaged ECG
acute myocardial infarction, OA, RT-104,
RT-105
frequency domain analysis, OA, RT-103
heart rate variability, OA, RT-104,
RT-105
high frequency components, OA, RT-103
left ventricular ejection fraction, OA, RT-104,
RT-105
mitral valve prolapse, OA, RT-106
myxomatous degeneration of mitral valve, OA, RT-106
paroxysmal atrial fibrillation, OA, RT-103
predictors of clinical outcome, OA, RT-104
risk of sudden death, OA, RT-106
risk stratification, OA, RT-105
time domain analysis, OA, RT-103
|
TOP OF THE PAGE
|
ST-segment alterations
supraventricular tachycardia, OA, RT-46
ventricular repolarization, OA, RT-46
|
TOP OF THE PAGE
|
Sudden death
amiodarone, R, RT-168
anomalous coronary artery origin, R, RT-171
aortic rupture, R, RT-171
athletes, R, RT-171
autonomic nervous system, R, RT-169
behavioral-psychological factors, R, RT-169
blood transfusion, R, RT-168
bradyarrhythmias, R, RT-168
CAPS trial, R, RT-169
cardiac mortality risk, R, RT-169
Chagasดheart disease, R, RT-168
congenital anomaly, R, RT-171
congenital form, R, RT-168
depression, R, RT-169
dilated cardiomyopathy, R, RT-168
dopamine tone, R, RT-169
electrical alternans, R, RT-170
embolismus, R, RT-168
heart failure, R, RT-168
hypertrophic cardiomyopathy, R, RT-170,
RT-171
insect vectors, R, RT-168
left bundle branch block, R, RT-170
long QT syndrome, R, RT-170
mortality risk stratification, R, RT-170
post myocardial patients, R, RT-169
premature coronary atherosclerosis, R, RT-171
premature ventricular contractions, R, RT-169
proarrhythmia, R, RT-168
prolongation of repolarization, R, RT-170
public health problem, R, RT-168
right ventricular cardiomyopathy, R, RT-171
strenous exercise, R, RT-171
triggers, R, RT-171
T-wave alternans, R, RT-170
vasospasm, R, RT-171
ventricular arrhythmias, R, RT-168
WPW syndrome, R, RT-171
young population, R, RT-171
|
TOP OF THE PAGE
|
Syncope
adenosine triphosphate sensitivity, OA, RT-34
aortic stenosis, R, RT-32
atrio-ventricular conduction, OA, RT-34
cardioinhibitory response, R, RT-32
nitroglycerin, OA, RT-35
orciprenaline, OA, RT-33
orthostatic intolerance, OA, RT-36
salt intake, OA, RT-37
tilt training, OA, RT-36
vasodepressor response, R, RT-32
|
TOP OF THE PAGE
|
Third degree interatrial block
medical treatment, R, RT-12
paroxysmal tachyrrhythmias, R, RT-12
synchronous biatrial pacing, R, RT-12
|
TOP OF THE PAGE
|
Treatment of arrhythmias mechanisms
amiodarone, R, S-7
atrial fibrillation, R, S-65, S-66
atrial flutter, R, S-65
AVID trial, R, S-7
BASIS trial, R, S-7
CABG-Patch trial, R, S-7
CAMIAT trial, R, S-7
CAST trial, R, S-7, S-63
cellular changes in ion channels, R, S-63
CHF-STAT trial, R, S-7
class Ic, III drugs, R, S-7
congenital long QT syndrome, R, S-65,
S-63
electrical remodeling, R, S-63
EMIAT trial, R, S-7, S-66
EPAMSA trial, R, S-7
gene disease, R, S-7, S-63
GESICA trial, R, S-7
heart failure, R, S-63
ICD therapy, R, S-7
molecular arrhythmology, R, S-63
molecular biology, R, S-7
MADIT trial, R, S-7, S-66
multiplicity of factors, R, S-65
PAT trial, R, S-7
primary prevention, R, S-7
secondary prevention, R, S-7
sudden death, R, S-63
supraventricular arrhythmias, R, S-66
SWORD trial, R, S-7, S-63
ventricular fibrillation, R, S-65
ventricular tachiarrhythmias, R, S-66
vulnerable parameters, R, S-65
|
TOP OF THE PAGE
|
Treatment of arrhythmias - pharmacological
management
aetiology of heart disease, OA, RT-131
amiodarone, OA, RT-156
amiodarone, R, RT-130
angiotensin II receptor blockers, OA, RT-155
arterial hypertension, OA, RT-155
atrial fibrillation, R, S-112
atrial flutter, R, S-112
atropine, OA, RT-156
AVID trial, R, RT-130
burst of impulses, OA, RT-153
CAST trial, R, RT-129
CAMIAT trial, R, RT-130
CASCADE trial, R, RT-130
CHF-STAT trial, R, RT-130
chronic atrial fibrillation, OA, RT-156
CIDS trial, R, RT-130
class III drugs, OA, RT-154
class III drugs, R, S-112
clinical presentation, OA, RT-131
converting enzyme inhibitors, OA, RT-155
dl-sotalol, R, S-112
electrical cardioversion, OA, RT-156
EMIAT trial, R, RT-130
enalapril, OA, RT-155
ESVEM trial, R, RT-130
flecainide, OA, RT-153, RT-156
GESICA trial, R, RT-130
ibutilide, R, S-112
left ventricular function, OA, RT-131
MADIT II trial, R, RT-130
malignant ventricular arrhythmias, R, RT-130
metoprolol, R, RT-129
monomorphic ventricular tachycardia, OA, RT-131
myocardial remodeling, OA, RT-155
overdrive pacing, OA, RT-153
paroxysmal atrial flutter, OA, RT-153
pharmacologic conversion, R, S-112
procainamide, R, S-112
propranolol, R, RT-129
QRS-tachycardia morphology, OA, RT-131
QT dispersion, OA, RT-155
risk of torsade de pointes, R, S-112
SCD-HeFT trial, R, RT-130
sotalol, OA, RT-154
sudden death, R, RT-129, RT-130
supraventricular paroxysmal tachyarrhythmias, OA, RT-154
survival, OA, RT-131
sustained ventricular arrhythmias, R, RT-129
synergistic interaction, R, RT-130
transoesophageal atrial pacing/recording, OA, RT-153
ventricular arrhythmias, OA, RT-155
ventricular extrasystols, OA, RT-154
ventricular hyperophy, OA, RT-155
ventricular dilatation, RT-155
|
TOP OF THE PAGE
|
T-wave interval
Holter ECG, OA, RT-45
myocardial infarction, OA, RT-45
programmed ventricular stimulation, OA, RT-48
ventricular tachyarrhythmias, OA, RT-48
ventricular tachycardia, OA, RT-45
|
|
|
|
